WASHINGTON, D.C. — Congressman Buddy Carter (R-GA) and Senator Tom Cotton (R-Arkansas) sent a letter today to Seileen Mullen, the Acting Assistant Secretary of Defense for Health Affairs, seeking answers about the recent announcement that a pharmacy benefit manager (PBM), Express Scripts, will strip pharmaceutical access away from TRICARE patients and their families, a move that… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA) and Deborah Ross (D-NC) introduced bipartisan legislation today that will increase patients’ access to pharmaceuticals by cutting unnecessary bureaucracy within the Drug Enforcement Agency (DEA).
The Improving Access to Safe Medicines Act will ensure that the DEA makes timely decisions on whether to de-schedule drugs recommended… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Tony Cárdenas (D-CA) and Sanford D. Bishop, Jr. (D-GA) today introduced The Access to Critical Non-Emergency Transportation Services Act, which expands access to non-emergency medical transportation (NEMT) for vulnerable dual-eligible Medicare and Medicaid patients.
Currently, Medicare beneficiaries must obtain prior… Read more »
WASHINGTON, D.C. — Rep. Earl L. "Buddy" Carter (GA-01) formed the bipartisan Congressional Domestic Pharmaceutical Manufacturing Caucus, a new working group in Congress that will focus on re-shoring and protecting the U.S.’s pharmaceutical manufacturing base.
The Caucus plans to help advance legislation that incentivizes more domestic production for critical… Read more »
WASHINGTON, D.C. – The Food and Drug Administration (FDA) finalized a rule today that will increase access to hearing aids by making them available over-the-counter, an issue Rep. Earl L. “Buddy” Carter (R-GA) has been championing since 2017:
“Hearing aids should be just as accessible as reading glasses,” said Carter. “Only 1 in 5 Americans who need a hearing aid use one, mainly due to… Read more »
WASHINGTON, D.C. – The House today passed H.R. 4040, the Advancing Telehealth Beyond COVID-19 Act, which included provisions from Rep. Earl L. “Buddy” Carter’s (R-GA) Greater Access to Telehealth Act that will expand access to telehealth services.
“As a pharmacist who grew up in South Georgia, I know first-hand how difficult access to health care can be for rural Americans,”… Read more »
WASHINGTON, D.C. – Following last week’s Department of Health and Human Services (HHS) guidance warning pharmacists that they may be in violation of civil rights laws if they do no fill prescriptions for elective abortions, Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, sent a letter highlighting the widespread legal and ethical consequences of the irresponsible guidance.… Read more »
WASHINGTON, D.C. – The Energy and Commerce Committee today passed the bipartisan Lymphedema Treatment Act, which expands Medicare coverage to include necessary compression treatment items for Lymphedema.
Nearly 5 million people suffer from this disease nationwide, which is frequently the result of cancer treatments and causes life-long, painful swelling that can impede daily… Read more »
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) will now allow authorized, state-licensed pharmacists to prescribe Paxlovid, an oral treatment for COVID-19.
Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, sees this Emergency Use Authorization expansion as the necessary link between COVID-19 patients and treatment:
“Pharmacists are the… Read more »
WASHINGTON, D.C. – In the face of a nationwide mental health crisis, the U.S. House of Representatives, with support from Rep. Earl L. “Buddy” Carter (R-GA), today passed the bipartisan Restoring Hope for Mental Health and Well-Being Act, which will improve school safety for young Americans and provide necessary aid to those suffering from severe mental illness.
“This is how we heal… Read more »
